Application 218364
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 500MG/100ML (5MG/ML) | No | No |
| 002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1GM/100ML (10MG/ML) | No | No |
| 003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1.5GM/100ML (15MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | |
| A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | |
| A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218364-001 | AP |
| A218364-002 | AP |
| A218364-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218364-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | American Health Packaging | 031a32e1-675a-4efe-a66b-40beb4fe5101 | 2024-06-21 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Amneal Pharmaceuticals LLC | 5c4877cc-52bc-4f98-a995-0aa9439da742 | 2024-06-11 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam ER | LEVETIRACETAM | Westminster Pharmaceuticals, LLC | c508a392-0603-477d-8a45-3ec550371111 | 2024-06-10 | Warnings, Adverse reactions | LEVETIRACETAM |
| LEVETIRACETAM | LEVETIRACETAM | Hospira, Inc. | f1935bc8-30ce-4b51-8a4c-0f12ce9000a6 | 2024-06-05 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | bc8b413f-2f07-4e6a-bb8e-a1f2119ae1cf | 2024-05-30 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Actavis Pharma, Inc. | 5cb4a1db-f32d-44af-8985-0a94ca506468 | 2024-05-30 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | adbcb0f7-0421-47e2-854e-e1cfefb6386f | 2024-05-29 | Warnings, Adverse reactions | LEVETIRACETAM |
| levetiracetam | LEVETIRACETAM | Mylan Institutional LLC | e86dc508-4d22-493b-bdf1-408b6484d3f1 | 2024-05-28 | Warnings, Adverse reactions | LEVETIRACETAM |
| LEVETIRACETAM | LEVETIRACETAM | Hospira, Inc. | ed1b74a8-2a9b-4315-b051-673c7941cb13 | 2024-05-14 | Warnings, Adverse reactions | LEVETIRACETAM |
| levetiracetam | LEVETIRACETAM | Baxter Healthcare Corporation | 3d88adda-9580-44bf-b75c-d615c973c1e1 | 2024-05-06 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam in Sodium Chloride | LEVETIRACETAM | Nexus Pharmaceuticals LLC | ee014183-a857-457b-9573-0cc168e560f3 | 2024-04-30 | Warnings, Adverse reactions | Levetiracetam in Sodium Chloride LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Camber Pharmaceuticals, Inc. | 63b36274-89f0-42d8-9f09-f9e78e179af4 | 2024-04-29 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | B. Braun Medical Inc. | ad32ec2f-b4e0-4811-8ea1-7a4abdd5c0a6 | 2024-04-23 | Warnings, Adverse reactions | LEVETIRACETAM |
| levetiracetam | LEVETIRACETAM | Sagent Pharmaceuticals | d2de9565-0c0b-4957-bafa-1a286103709e | 2024-04-18 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam in Sodium Chloride | LEVETIRACETAM IN SODIUM CHLORIDE | Hikma Pharmaceuticals USA Inc. | c723fd27-214c-45f6-b170-a3b807ffab07 | 2024-04-12 | Warnings, Adverse reactions | Levetiracetam in Sodium Chloride |
| Levetiracetam | LEVETIRACETAM | Aurobindo Pharma Limited | 2471ee03-d747-4113-86d0-1aa93c8f3eba | 2024-04-04 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Novadoz Pharmaceuticals LLC | 484e8d8f-be40-46f8-a509-d1bbdbbd2981 | 2024-04-04 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | ed8e88d0-993e-4683-bdcf-31578130d3df | 2024-04-03 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | WG Critical Care, LLC | 62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926 | 2024-03-29 | Warnings, Adverse reactions | LEVETIRACETAM |
| LEVETIRACETAM | LEVETIRACETAM | Solco healthcare U.S., LLC | bc8644ed-3320-47b5-adf3-8b972bea8abd | 2024-03-28 | Warnings, Adverse reactions | LEVETIRACETAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.